Neovate Capital Partners is a Denver-based venture capital firm investing in early-stage life sciences companies, with emphasis on seed to Series A opportunities in medical devices and therapeutics. It backs transformational devices, category-defining therapeutics, robotic and AI-enabled systems, and procedure-based drugs and biologics, and has investment exposure across the United States and United Kingdom. The firm is relevant for founders in HealthTech, MedTech, biotechnology, pharmaceuticals, robotics, and AI-enabled healthcare.